基本信息
浏览量:12
职业迁徙
个人简介
Dra. Figueroa is Head of the Epithelial Plasticity & Metastasis Group at Biomedical Research Institute A Coruña (INIBIC) belonging to the University Hospital Complex of La Coruña (CHUAC). Her group is integrated by basic researchers and clinicians, including gastrointestinal surgeons, pathologists, urologists and oncologists. The goal of her team is to translate the results on cancer from bench to bedside. Her group is focused on the study of the molecular mechanisms involved in epithelial plasticity during tumor progression, metastasis and drug resistance, describing new therapeutic targets, novel molecular biomarkers, and new antitumor agents contributing into the precision oncology.
Figueroa earned her bachelor's degree in biology from Complutense University of Madrid and her doctoral degree from Autonoma University of Madrid. During her phD she described, for the first time, the critical function for the RNA binding protein HuR during skeletal myogenesis in vitro and in vivo linked to HuR's coordinate regulation of muscle differentiation genes. She has more than six years-experience in prestigious international institutions. She completed her formation with two short-term stays at the IMB from Queensland University, (Australia, 2001) and at the National Institute on Aging- NIH (USA, 2002). Then, she trained as a postdoctoral researcher at the LMCB - Medical Research Council at the University College London (2003-2008). As postdoctoral fellow, she described the role of CK-1 and Hakai as novel posttranslational regulators of the E-cadherin protein during tumor progression. In 2009, she moved to INIBIC to establish her own research group (www.epithelial-plasticitymetastasis.com). Since 2010, she has received continuous private and public in competitive calls including ISCIII, Consellería of Health and Consellería of Industry from Galician Xunta, Pierre Fabre SA, Gilead and San Rafael Foundation.
She has experience in carry out innovation projects supported by CDTI, in collaboration with CZVeterinaria and Hifas da Terra biotechnological companies. In 2012, she received the XIX San Rafael Prize in recognition of the excellence of the scientific work in cancer research. She is inventor of 4 filled patents related to cancer treatment and diagnosis. The results of her group have been also supported by transfer programs: CaixaImpulse Validate from La Caixa Foundation, the pre-commercial development program from Galician Public health System (PRIS3 program, ACIS-Xunta de Galicia), the Foundation for Innovation and Prospective in Health (FIPSE) and the BioIncubaTech initiative, a high-technology incubator for the promotion of innovation and biotechnology transfer in the field of health.
She is currently supervising 1 postdoctoral fellow 4 phD students and 1 master student. In 2020, her group was accredited as a Competitive Research Unit from Xunta de Galicia (GAIN) and since 2021, she also leads innovative projects selected in two prestigious and competitive programs: the CaixaResearch Consolidate from “la Caixa” Foundation and the Ignicia-proof of Concept (GAIN, Xunta de Galicia), reaching 0.9M€. Her goal is to develop-up to clinical proof-of-conceot a first-in class inhibitor against carcinoma metástasis.
Dra. Figueroa has 36 high-impact publications specialized in oncology and molecular biology (H-index 25, ≈1900 cites,) and 6 book chapters. She participates in several national networks (REGICC, REGID, REDEFAR community) and in European COST actions (Horizon 2020 Framework Program). She is Editorial Board Member in Cancers and reviewer in journals such as Mol. Can., Can. Res., Theranostics, Cell Comm. and Sign., Cancers... She is expert, external reviewer and participates in evaluation committees in the National Agency or Research (AEI) and in Andalusia Agency (DEVA), as well as in other public and private entities from national and international agencies (Argentina, Colombia between others). She was Directive Board Member of the Spanish Association of Cancer Research (ASEICA, 2017-2020), and cofounder of the ASEICA-Woman group. She has been invited as speaker in conferences, participates in the organization of workshops/congress and is member of several scientific cancer-related societies such as European Association of Cancer Research (EACR), Metastasis Research Society (MRS), International Association of EMT (TEMTIA), ASEICA, SEOM, SEBBM. She actively collaborates in scientific dissemination in social media and network (press, radio, TV, twiter, linkedin) and in collaboration with patient associations such as Spanish Association of Cancer Research (AECC) and Sarcomas Association of Galicia (ASARGA).
研究兴趣
论文共 56 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 3 (2024): 1919
J. Escuder-Rodriguez, L. Jove-Filgueiras, G. Alfonsin-Rey, M. Quiroga-Fernandez, A. Rodriguez-Alonso,A. Figueroa
引用0浏览0引用
0
0
Foundations of Colorectal Cancerpp.543-550, (2022)
semanticscholar(2021)
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 56
#Citation: 1826
H-Index: 26
G-Index: 41
Sociability: 5
Diversity: 3
Activity: 28
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn